Buy Luciolap Olaparib 50mg online
Buy Luciolap Olaparib 50mg.Luciolap（lynparza）is a poly (ADP-ribose) polymerase (PARP) inhibitor indicated:Ovarian cancer1.for the maintenance treatment of adult patients with recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer, who are in a complete or partial response to platinum-based chemotherapy.2.for the treatment of adult patients with deleterious or suspected deleterious germline BRCA-mutated (gBRCAm) advanced ovarian cancer who have been treated with three or more prior lines of chemotherapy.
Select patients for therapy based on an FDA-approved companion diagnostic for Luciolap.Breast cancerin patients with deleterious or suspected deleterious gBRCAm, human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer who have been treated with chemotherapy in the neoadjuvant, adjuvant or metastatic setting.
Patients with hormone receptor (HR)-positive breast cancer should have been treated with a prior endocrine therapy or be considered inappropriate for endocrine therapy. Select patients for therapy based on an FDA-approved companion diagnostic for Luciolap.DOSAGE AND ADMINISTRATION1.To avoid substitution errors and overdose, do not substitute Luciolap tablets with Luciolap capsules on a milligram-to-milligram basis due to differences in the dosingand bioavailability of each formulation.
For adverse reactions, consider dose interruption or dose reduction.5.For moderate renal impairment (CLcr 31-50 mL/min), reduce dose to 200 mg twice daily.Luciolap’s brand name is lynparza® by AstraZeneca. Luciolap is a generic oncologic prescription medicine from Lucuis, which is the biggest pharmaceutical company in Bangladesh.More Prescribing information.
Buy Luciolap Olaparib 50mg now